European Society of Cardiology publishes recommendations on the EU Pharmaceutical Legislation Reform and urges for greater attention to cardiovascular research

Notes to editor

ESC Press Office
Tel: +33 (0)61 40 18 84

Email: [email protected]

Follow us on Twitter @ESCardioNews 

References:

¹Piotr Szymański, Eva Irene Bossano Prescott, Franz Weidinger, The first European Union approval of a new medicine to treat cardiovascular diseases in 2023: why is it important to collaborate with the European Medicines  Agency, European Heart Journal, 2023, https://doi.org/10.1093/eurheartj/ehad426

² Human Medicines Highlights 2022, EMA, 2023: https://www.ema.europa.eu/en/documents/report/human-medicines-highlights-2022_en.pdf

About the European Society of Cardiology

The ESC brings together health care professionals from more than 150 countries, working to advance cardiovascular medicine and help people to live longer, healthier lives.